We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Brief Therapies for Problem Gambling Substance Abusers

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00685048
First Posted: May 28, 2008
Last Update Posted: February 25, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
UConn Health
  Purpose
This project evaluates the efficacy of brief interventions for individuals seeking treatment for substance use disorders who also have gambling problems. In total, 220 problem gambling substance abusers will be randomized to one of three conditions: (a) a control condition consisting of 10 minutes of psychoeducation about gambling, (b) 10 minutes of brief advice about problem gambling and how to reduce it, or (c) four session of motivational and cognitive-behavioral therapy. Gambling, substance use and psychosocial problems will be assessed using standardized instruments at pre-treatment, month 2, 5, 8, 12, 16, 20 and 24-month follow-up evaluations.

Condition Intervention Phase
Gambling Behavioral: 10 minutes of psycho-education Behavioral: 10 minutes of brief advice Behavioral: four 50-minute individual therapy sessions of MET & CBT Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Brief Therapies for Problem Gambling Substance Abusers

Resource links provided by NLM:


Further study details as provided by UConn Health:

Primary Outcome Measures:
  • dollars and days gambled per month [ Time Frame: baseline and each follow-up ]

Enrollment: 220
Study Start Date: July 2007
Study Completion Date: January 2014
Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
psychoeducation
Behavioral: 10 minutes of psycho-education
Patients review with study therapist a brochure about types of gambling people engage in and relationships between gambling, drug use, moods, and legal problems.
Experimental: 2
brief advice
Behavioral: 10 minutes of brief advice
Patients will review with study therapist a brochure and advice about problem gambling. It will also contain methods for reducing gambling.
Experimental: 3
Motivational Enhancement Therapy (MET)/Cognitive-Behavioral Therapy (CBT)
Behavioral: four 50-minute individual therapy sessions of MET & CBT
MET & CBT

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • age > 18 years
  • current (past-year) DSM-IV criteria for alcohol, cocaine, opioid or marijuana abuse or dependence
  • score >3 on the past-two month SOGS
  • report an average of >2 gambling days per month for the past 2 months; (e) spent an average of >$50/month on gambling in the past 2 months
  • English speaking
  • sign informed consent.

Exclusion Criteria:

  • have uncontrolled major psychiatric disorders other than substance use that require inpatient hospitalization (e.g., active bipolar disorder, psychosis, suicidality)
  • desire specific gambling treatment or are currently receiving treatment for gambling
  • have severe cognitive impairment
  • read below 5th grade level
  • plan to relocate >100 miles or are likely to be incarcerated
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00685048


Locations
United States, Connecticut
University of Connecticut Health Center
Farmington, Connecticut, United States, 06030
Sponsors and Collaborators
UConn Health
National Institute on Drug Abuse (NIDA)
Investigators
Principal Investigator: Nancy M Petry, Ph.D. UConn Health Center
  More Information

Responsible Party: UConn Health
ClinicalTrials.gov Identifier: NCT00685048     History of Changes
Other Study ID Numbers: 07-108-2
R01DA021567 ( U.S. NIH Grant/Contract )
R01DA021567-01 ( U.S. NIH Grant/Contract )
First Submitted: May 23, 2008
First Posted: May 28, 2008
Last Update Posted: February 25, 2014
Last Verified: February 2014

Keywords provided by UConn Health:
Gambling
Brief Therapies
Substance Abuse

Additional relevant MeSH terms:
Gambling
Disruptive, Impulse Control, and Conduct Disorders
Mental Disorders